Last $0.23 HKD
Change Today +0.005 / 2.19%
Volume 10.1M
8158 On Other Exchanges
Symbol
Exchange
Hong Kong
Berlin
OTC US
As of 3:01 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

china bio-med regeneration (8158) Snapshot

Open
$0.23
Previous Close
$0.23
Day High
$0.24
Day Low
$0.23
52 Week High
02/10/14 - $0.40
52 Week Low
12/11/14 - $0.23
Market Cap
2.8B
Average Volume 10 Days
17.8M
EPS TTM
$-0.03
Shares Outstanding
11.9B
EX-Date
07/10/03
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA BIO-MED REGENERATION (8158)

Related News

No related news articles were found.

china bio-med regeneration (8158) Related Businessweek News

No Related Businessweek News Found

china bio-med regeneration (8158) Details

China Bio-Med Regeneration Technology Limited, an investment holding company, is engaged in the research, development, production, and sale of tissue engineering skin related products. The company’s tissue engineering skin products include ActivSkin, which is used to cure injuries due to accidents and diseases occurring from infection, ulcer, burn, complication of surgeries, and congenital abnormalities; and Acellular Cornea for the treatment of various kinds of cornea diseases, including cornea lamellar defect, cornea alkali burn, and bacteria corneal ulcer. Its other development products comprise Selective Acellular Porcine Skin for the treatment of various skin injuries, infected, and deficient wounds, as well as enhance healing of scars and chronic non-healing ulcers and prevent recurrence; and Boactive cosmetics. The company was formerly known as B M Intelligence International Limited and changed its name to China Bio-Med Regeneration Technology Limited in December 2008. China Bio-Med Regeneration Technology Limited was founded in 1995 and is headquartered in Wanchai, Hong Kong.

352 Employees
Last Reported Date: 07/30/14
Founded in 1995

china bio-med regeneration (8158) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: $1.2M
Executive Director
Total Annual Compensation: $1.4M
Compliance Officer and Executive Director
Total Annual Compensation: $1.4M
Compensation as of Fiscal Year 2014.

china bio-med regeneration (8158) Key Developments

China Bio-Med Regeneration Technology Limited Reports Consolidated Unaudited Earnings Results for the Second Quarter and Six Months Ended October 31, 2014

China Bio-Med Regeneration Technology Limited reported consolidated unaudited earnings results for the second quarter and six months ended October 31, 2014. For the quarter, the company reported revenues were HKD 730,000 against HKD 149,000 a year ago. Loss before income tax was HKD 42,862,000 against HKD 31,214,000 a year ago. Loss for the period attributable to owners of the company was HKD 39,128,000 or 0.331 HK cents basic per share against HKD 27,873,000 or 0.309 HK cents basic per share a year ago. For the six-month period, the company reported revenues were HKD 1,521,000 against HKD 196,000 a year ago. Loss before income tax was HKD 82,088,000 against HKD 52,462,000 a year ago. Loss for the period attributable to owners of the company was HKD 75,208,000 or 0.637 HK cents basic per share against HKD 46,730,000 or 0.519 HK cents basic per share a year ago. Net cash used in operating activities was HKD 71,167,000 against HKD 93,828,000 a year ago.

China Bio-Med Regeneration Technology Limited to Report First Half, 2015 Results on Dec 11, 2014

China Bio-Med Regeneration Technology Limited announced that they will report first half, 2015 results on Dec 11, 2014

China Bio-Med Regeneration Technology Limited, Board Meeting, Dec 11, 2014

China Bio-Med Regeneration Technology Limited, Board Meeting, Dec 11, 2014. Agenda: To consider unaudited consolidated interim results of the group for the six months ended 31 October 2014; to approve the publication of the interim results announcement on the websites of growth enterprise market of the stock exchange and the company, and the dispatch of the interim results report to the shareholders of the company; to consider the payment of dividends, if any; to consider and approve the closure of the register of members of the company, if necessary; and to transact any other business.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8158:HK $0.23 HKD +0.005

8158 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8158.
View Industry Companies
 

Industry Analysis

8158

Industry Average

Valuation 8158 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2,184.6x
Price/Book 3.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2,076.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA BIO-MED REGENERATION, please visit www.bmregeneration.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.